生物相容的核心外微针传感器充满Zwitterionic聚合物凝,用于快速连续的皮肤间监测
Shicheng Zhou1, Yutaro Chino2, Toshihiro Kasama1,3
1Department of Bioengineering, The University of Tokyo, Tokyo 113-8654, Japan.
ACS nano
|September 19, 2024
概括
这项研究引入了空心微针 (MN) 生物传感器,具有独特的水凝芯,用于稳定,非侵入性的生物标志物监测. 这些先进的MN传感器提供快速,灵敏和可靠的体内葡萄糖检测,具有出色的抗 capabilities.
科学领域:
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
- 电化学 电化学 电化学
背景情况:
- 基于微针 (MN) 的电化学生物传感器显示出对非侵入性间歇性流体生物标志物监测的前景.
- 不稳定性和生物污染是阻碍MN生物传感器临床应用的重大挑战.
研究的目的:
- 开发一种新型的空心MN生物传感器设计,采用一个zwitterionic聚合物水凝传感层.
- 通过理性设计和微纳米制造来应对MN生物传感器中不稳定性和生物污染的挑战.
主要方法:
- 从高分子量聚乳酸制造空洞的MN,使用绘图光刻法.
- 在空洞的MNs中封装一个zwitterionic聚合物水凝感应层.
- 黄金纳米导体层的沉积用于稳定的电气连接.
- 数字模拟和实验验证传感器性能.
主要成果:
- 成功地制造出具有足够强度的空心MNs,用于表皮透.
- 证明了卓越的生物相容性和zwitterionic水凝的防性质.
- 在电化学检测中实现了快速响应,高灵敏度和长期稳定性.
- 经过验证的准确和快速的体内葡萄糖监测能力与生物安全性.
结论:
- 拟议的空心MN设计有效地克服了传统MN生物传感器的局限性.
- 理性设计,结构利用和微纳米制造对于推进MN生物传感器技术至关重要.
- 这种创新方法释放了MN生物传感器在持续,非侵入性健康监测方面的潜力.
相关概念视频
Modified-Release Drug Delivery Systems: Stimuli-Activated
184
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
184
Site-Targeted Drug Delivery Systems: Polymeric Carriers
165
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
165
Transdermal Drug Delivery Systems
238
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
238


